Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-16

FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)

View source ↗

Summary

FDA approved a supplemental application for isotretinoin by Mayne Pharma, expanding the labeling for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

SUPPL AP for ISOTRETINOIN (ISOTRETINOIN)